Surgery Partners CS (SGRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 182,300 | 239,900 | 203,400 | 250,100 | 229,300 |
| Receivables | 603,400 | 602,200 | 579,300 | 563,100 | 570,600 |
| Inventories | 100,500 | 96,600 | 92,300 | 87,300 | 88,100 |
| Other current assets | 157,500 | 170,900 | 182,500 | 158,900 | 150,300 |
| TOTAL | $1,082,500 | $1,150,700 | $1,102,200 | $1,105,300 | $1,074,600 |
| Non-Current Assets | |||||
| PPE Net | 1,134,900 | 1,153,400 | 1,164,000 | 1,179,500 | 1,151,100 |
| Investments And Advances | 225,400 | 234,000 | 229,400 | 220,200 | 218,600 |
| Other Non-Current Assets | 5,599,300 | 5,581,600 | 5,451,000 | 5,449,800 | 5,504,900 |
| TOTAL | $6,959,600 | $6,969,000 | $6,844,400 | $6,849,500 | $6,874,600 |
| Total Assets | $8,042,100 | $8,119,700 | $7,946,600 | $7,954,800 | $7,949,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 100,400 | 99,300 | 103,000 | 110,000 | 103,900 |
| Accounts payable and accrued liabilities | 168,600 | 208,700 | 174,600 | 174,900 | 165,000 |
| Accrued Expenses | 77,100 | 64,900 | 69,900 | 59,300 | 67,000 |
| Other current liabilities | 235,600 | 242,600 | 238,500 | 229,100 | 233,500 |
| TOTAL | $581,700 | $615,500 | $586,000 | $573,300 | $569,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,613,500 | 3,602,900 | 3,460,600 | 3,465,200 | 3,446,900 |
| Other Non-Current Liabilities | 663,100 | 672,600 | 667,400 | 675,000 | 700,600 |
| TOTAL | $4,362,500 | $4,372,900 | $4,218,600 | $4,225,000 | $4,223,800 |
| Total Liabilities | $4,944,200 | $4,988,400 | $4,804,600 | $4,798,300 | $4,793,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 130,788 | 129,420 | 129,342 | 128,209 | 128,160 |
| Common Shares | 1,300 | 1,300 | 1,300 | 1,300 | 1,300 |
| Retained earnings | -851,100 | -815,200 | -800,200 | -777,500 | -775,000 |
| Other shareholders' equity | 1,399,400 | 1,404,600 | 1,398,100 | 1,394,900 | 1,403,800 |
| TOTAL | $3,097,900 | $3,131,300 | $3,142,000 | $3,156,500 | $3,156,000 |
| Total Liabilities And Equity | $8,042,100 | $8,119,700 | $7,946,600 | $7,954,800 | $7,949,200 |